n.hartmann
TL2 · Palermo
Contributes reviews on supplier material. Based in Palermo.
Joined 17 November 2024 · last posted 1d
96 posts, newest first. Showing up to 150.
-
Packaging that arrived damaged: documenting it properly Replied, post #50 · Sourcing › Logistics · 27 Jul 2026 · 31 likes This follows post #47 rather than contradicting it. Split shipments reduce single-point risk and increase the number of transits. Which trade is right depends on what…
-
The five documentation pages worth reading before you post anything — a second dataset Replied, post #3 · marked as the solution · Start Here › Welcome · 27 Jul 2026 · 26 likes The compound and evidence pages are updated regularly and they are worth reading when you are new. They answer the meta questions like "do we have data on this" and…
-
Why the absence of controlled human data on BPC-157 matters more than people admit Replied, post #66 · Compounds › Repair & healing peptides · 25 Jul 2026 · 2 likes Oral versus injected administration claims for BPC-157: the preclinical work studied injection. Oral claims are common in supplier marketing and poorly supported by…
-
Follow-up: The most useful thing you learned here that was not the answer you came for Replied, post #31 · Lounge › Off topic · 22 Jul 2026 · 1 like A digression that keeps occurring to me: the most-linked documents here are the dullest ones. Nothing gets cited like the unit-arithmetic page. That holds for the case…
-
Why a glucagon receptor agonist in a weight-loss compound is not a contradiction Replied, post #38 · Compounds › Retatrutide · 18 Jul 2026 · 1 like Heart rate increased in a dose-dependent way in the phase 2 work. That is not a footnote — it is one of the specific things phase 3 exists to characterise, and it is…
-
Revisiting: Journal club: SURMOUNT-OSA and a hard endpoint in a soft field Replied, post #110 · Evidence › Journal club · 16 Jul 2026 · 0 likes Post #108 describes the usual case. This is about the unusual one. Sessions on negative or null results are consistently the most instructive and the hardest to get…
-
How shortages have affected compounding permissions Replied, post #38 · Access › Shortages · 14 Jul 2026 · 4 likes Source for the shortages figure, since it was asked for. It is in the discussion rather than the abstract, which is why the version circulating is stronger than the…
-
Osteoarthritis and mechanical versus metabolic improvement — one year on Replied, post #51 · Clinical › Comorbidities · 13 Jul 2026 · 9 likes Nothing here is medical advice and clinicians posting in this subcategory say so on their own account rather than because a rule requires it. I would not lead a…
-
Follow-up: Reading an interaction checker output critically Replied, post #43 · Practice › Interactions · 12 Jul 2026 · 0 likes Oral medications with a narrow therapeutic index are the ones where that matters most. The interaction is about rate and timing rather than about the total absorbed, in…
-
Follow-up: Comparing two chromatograms from different laboratories, properly Replied, post #57 · Analytics › HPLC & UHPLC · 9 Jul 2026 · 1 like Post #56 answers the question as asked. The question underneath it is different. If two laboratories disagree by more than two or three percentage points, work through…
-
Reading a rodent study on a secretagogue without over-extrapolating — the long version Replied, post #29 · Compounds › Secretagogues & GH axis · 8 Jul 2026 · 0 likes Post #27 put the caveat in the right place and I want to underline it. CJC-1295 with and without DAC: the version with a drug affinity complex binds albumin covalently…
-
[2026 update] Travelling with an injectable: documentation and practicalities Replied, post #60 · Access › International · 6 Jul 2026 · 4 likes Regulatory position dates: a regulatory position is only current as of when it was written. Rechecking is prudent, especially if you saw it months ago. I have…
-
Reflectance and photometric devices: precision in practice — a second dataset Replied, post #65 · Analytics › Home & field testing · 5 Jul 2026 · 0 likes The right question for any home test is: what physical quantity does it measure, and what would have to be true for that quantity to answer your question? Most…
-
I joined for one answer and stayed for a year — what changed my mind Replied, post #34 · Start Here › Welcome · 21 Jun 2026 · 0 likes The Lounge is a real category rather than a dumping ground. The sourcing rule still applies there, which surprises people, but the register is looser and nobody minds a…
-
Second pass at: Which categories are strict and which are relaxed, honestly Replied, post #75 · Start Here › Welcome · 15 Jun 2026 · 8 likes The Lounge is a real category rather than a dumping ground. The sourcing rule still applies there, which surprises people, but the register is looser and nobody minds a…
-
Tracking intake honestly when appetite is absent Replied, post #56 · Nutrition & Training › Protein & intake · 11 Jun 2026 · 0 likes Tracking intake for a week rather than permanently is usually enough to find out whether there is a problem. Permanent tracking has its own costs.
-
A certificate whose chromatogram axes do not match its stated method — one year on Replied, post #15 · Sourcing › Red flags · 3 Jun 2026 · 0 likes Nothing here should be read as an accusation against a named company, and the guidelines exist so that reports remain reports. Take the reasoning and check the…
-
A 5 mg vial and a 0.25 mg dose: the arithmetic in full Replied, post #68 · Practice › Reconstitution · 2 Jun 2026 · 18 likes Filter needles are worth considering if you are drawing from a glass ampoule and are pointless overhead for a stoppered vial. The trade is dead volume against…
-
What I would want from a home test that does not exist yet Replied, post #2 · Analytics › Home & field testing · 1 Jun 2026 · 0 likes Picking up the opening post: that is the part I would want checked first. Why third-party testing is stronger: a home test run by the person who made the compound is a…
-
Shoulders, tangent skims, and defensible integration Replied, post #5 · Analytics › HPLC & UHPLC · 31 May 2026 · 0 likes Taking post #4 at face value and following it one step further. Where the shoulders reasoning breaks down for me is the step from the group result to the individual…
-
Research-use-only status: what it means legally and practically Replied, post #49 · Compounds › Other compounds · 28 May 2026 · 2 likes The tanning compounds carry a specific practical point that is not pharmacological: any change to a pigmented lesion is a reason to see a clinician, and that is not a…
-
Secretagogues and glucose tolerance: the mechanistic concern Replied, post #13 · Compounds › Secretagogues & GH axis · 26 May 2026 · 17 likes On secretagogues and glucose tolerance I would separate what is worth knowing from what is worth acting on. The first list is long and the second is short, and…
-
Peak-to-trough ratio at steady state for a weekly agent — the long version Replied, post #10 · Pharmacology › Pharmacokinetics · 24 May 2026 · 7 likes Adding the measurement that post #7 says would settle it. Before the thread moves on from Peak-to-trough ratio — what is the sample size behind the claim? I am not…
-
Molecular mass of semaglutide and why the figure differs between sources Replied, post #59 · Compounds › Semaglutide · 19 May 2026 · 0 likes Molecular mass of semaglutide is worth one more sentence than it usually gets, and the sentence is the one about how the number was arrived at.
-
Follow-up: Search filters: what is missing Replied, post #98 · Meta › Site feedback · 10 May 2026 · 0 likes A request rather than an answer: could whoever has the primary source for Search filters post it? I have seen the claim three times this month and each version had lost…
-
Why this subcategory is stricter about sourcing than most Replied, post #26 · Compounds › Secretagogues & GH axis · 5 May 2026 · 6 likes Reconstitution volumes in this family are often small enough that dead volume in the syringe is a meaningful fraction of the dose. A fixed-needle insulin syringe is…
-
[2026 update] Regional warehouse stock versus direct despatch Replied, post #55 · Sourcing › Logistics · 29 Apr 2026 · 8 likes Taking post #54 at face value and following it one step further. Whatever the answer on Regional warehouse stock versus direct turns out to be, the method for getting…
-
Converting between mg/mL and units per dose, both directions — the long version Replied, post #123 · Practice › Reconstitution · 25 Apr 2026 · 18 likes The arithmetic in post #122 is right; the assumption feeding it is the part to check. Preservative effectiveness is tested against a defined microbial challenge under…
-
Foaming during reconstitution and whether it matters — the long version Replied, post #109 · Practice › Reconstitution · 23 Apr 2026 · 10 likes Preservative effectiveness is tested against a defined microbial challenge under defined conditions. It is not a licence to treat an entered vial as sterile…
-
Price changes over 2025 and 2026, tabulated and dated — does this still hold? Replied, post #153 · Access › Pricing · 20 Apr 2026 · 6 likes A cheaper option that arrives slowly has a cost in the form of running out, and people rarely price that. This has been discussed before and I could not find the…
-
Converting between mg/mL and units per dose, both directions — the long version Replied, post #29 · Practice › Reconstitution · 19 Apr 2026 · 11 likes Worked example, since the arithmetic is the whole question. Five milligrams into one millilitre is 5 mg/mL. A 0.25 mg dose is 0.05 mL, which is five units on a U-100…
-
Grapefruit: why this class is not the class that cares Replied, post #79 · Practice › Interactions · 25 Mar 2026 · 0 likes I read the earlier replies on grapefruit twice before writing this, because I had assumed the opposite and wanted to be sure I was disagreeing with what was said rather…
-
Follow-up: Bug report: the reconstitution calculator and a rounding edge case Replied, post #56 · Data & Tools › Calculators · 24 Feb 2026 · 22 likes The most common input error is entering the vial mass in the concentration field. It produces a plausible number, which is why it survives.
-
Stepping down deliberately, and how to do it without losing progress Replied, post #63 · Practice › Dosing & titration · 23 Feb 2026 · 1 like Escalating before steady state means you are judging a dose you have not yet fully experienced. That is the whole argument against compressing the schedule and it is a…
-
Mass error in ppm: the arithmetic and the caveat Replied, post #15 · Analytics › Mass spectrometry · 12 Feb 2026 · 0 likes Acknowledging rather than arguing. The reasoning holds as far as I can follow it.
-
Coming back to: Why most self-reports here are not experiments, and that is fine Replied, post #43 · Research Methods › N-of-1 designs · 6 Feb 2026 · 11 likes Everything in post #41 holds. The case it does not cover is the one I have. Order effects matter. If you always try A before B, you cannot separate the treatment from…
-
What "marked as solution" means and who gets to mark it — does this still hold? Replied, post #38 · Start Here › Welcome · 3 Feb 2026 · 7 likes Trust levels accumulate over time and they give you access to small things like the ability to edit your own posts without a timestamp. They are not a status symbol and…
-
Is there a ceiling dose beyond which semaglutide stops adding benefit? Started this topic · Compounds › Semaglutide · 28 Jan 2026 · 43 likes Is there a ceiling dose beyond which semaglutide stops adding benefit? I have a specific reason for asking rather than idle curiosity, and the context is below. Putting…
-
A partial dose because the pen emptied mid-injection Replied, post #31 · Practice › Administration · 8 Jan 2026 · 23 likes Two claims get bundled together under partial dose because the pen and they need separating. The descriptive one — this is what was observed — is usually well…
-
When to stop reading forums, including this one Replied, post #72 · Wellbeing › Mental health · 6 Jan 2026 · 14 likes Expectations set by other people's reported trajectories are a documented source of distress, and the trajectories posted are not representative.
-
Second pass at: Adsorptive losses at low concentration, and why dilute solutions are… Replied, post #8 · Practice › Storage & stability · 28 Dec 2025 · 2 likes Good question, well framed, and I would like to see it answered properly.
-
Moderation log format change Replied, post #15 · Meta › Announcements · 18 Dec 2025 · 0 likes Where I part company with post #13, and it is a narrow parting. One question about the transition rather than the policy: what happens to topics that are in flight when…
-
Revisiting: Review: an evidence digest and the citation check that delayed it Replied, post #37 · Documentation › Doc review · 7 Dec 2025 · 20 likes Where content is lifted from a topic, attribution should be in the document rather than only in the review thread. That is the practical version. The rigorous version…
-
Persistent vomiting and the threshold for seeking help Replied, post #74 · Safety › Adverse events · 22 Nov 2025 · 1 like A definition problem is doing most of the work in this persistent vomiting discussion. Once the term is pinned down I suspect the disagreement mostly goes away and what…
-
Why "add 2 mL" is not an instruction Replied, post #8 · Practice › Reconstitution · 15 Nov 2025 · 2 likes Do not shake. Swirl, or leave it. Vigorous agitation introduces air and shear, and neither helps a peptide go into solution any faster than patience does. Reading it…
-
Why oral semaglutide needs an absorption enhancer at all Replied, post #49 · Compounds › Oral incretins · 12 Nov 2025 · 29 likes Nothing to add, except that this is the answer I would give if asked.
-
[2026 update] A single out-of-range value on an otherwise normal panel Replied, post #19 · Clinical › Bloodwork · 1 Nov 2025 · 11 likes A trend needs at least three points to be a trend. Two points are a line and a line through noise is still a line.
-
SURMOUNT-4 and what withdrawal data does and does not tell an individual — one year on Replied, post #24 · Compounds › Tirzepatide · 19 Oct 2025 · 25 likes Reading back through, this was answered upthread and I missed it. My fault.
-
Older adults, sarcopenia risk, and the trade-off nobody quantifies — the long version Replied, post #37 · Clinical › Special populations · 18 Oct 2025 · 1 like The reason Older adults is hard to answer is that the obvious measurement and the relevant quantity are not the same thing, and substituting one for the other is silent.
-
Second pass at: Robustness: the parameters worth deliberately varying Replied, post #17 · Analytics › Method validation · 5 Oct 2025 · 8 likes Forced degradation studies: deliberately stress the material with acid, base, oxidant, heat, light to generate degradation products and demonstrate that the method can…
-
What this community means by "a source", in practical terms Replied, post #107 · Start Here › Welcome · 10 Sep 2025 · 22 likes If you want a fast orientation, read three solved topics in the subcategory you care about. Solved means somebody said the answer worked, which is more signal than…
-
Are there stupid questions here? A staff answer, at length Replied, post #126 · Start Here › Welcome · 29 Aug 2025 · 9 likes The Lounge is a real category rather than a dumping ground. The sourcing rule still applies there, which surprises people, but the register is looser and nobody minds a…
-
Follow-up: The decimal-point error, and the habit that catches it Replied, post #46 · Practice › Reconstitution · 22 Aug 2025 · 0 likes Do not shake. Swirl, or leave it. Vigorous agitation introduces air and shear, and neither helps a peptide go into solution any faster than patience does. For what it…
-
Coming back to: Why quantitation is the hard part, not detection Replied, post #54 · Analytics › Home & field testing · 21 Aug 2025 · 0 likes Narrowing post #53, because the general version has more than one answer. Trying to state the quantitation position in a way that someone who disagrees would recognise…
-
Second pass at: LOD and LOQ: definitions people get wrong Replied, post #7 · Analytics › Method validation · 20 Aug 2025 · 21 likes Precision has two levels worth distinguishing: repeatability within a run and intermediate precision across days, analysts and instruments. The second is where most…
-
Coming back to: Cross-border purchase rules within the EU Replied, post #17 · Regional › European Union · 19 Aug 2025 · 0 likes The arithmetic in post #14 is right; the assumption feeding it is the part to check. Movement of medicines between member states for personal use has rules, and they…
-
Immortal time bias in a claims-database study Replied, post #22 · Evidence › Study critique · 16 Aug 2025 · 21 likes I have three months of notes on immortal time bias and the honest summary is that the trend is real and the week-to-week numbers are noise. I nearly drew the opposite…
-
Detection wavelength and why 214 nm and 280 nm disagree Replied, post #31 · Analytics › HPLC & UHPLC · 11 Aug 2025 · 0 likes Detection wavelength: 214 nm detects the peptide bond and is relatively insensitive to composition. 280 nm detects aromatic residues and is strongly…
-
Follow-up: Why we hide unevidenced fraud accusations and log the hiding Replied, post #11 · Sourcing › Red flags · 27 Jul 2025 · 27 likes Bookmarking this. I will come back when I have something worth adding.
-
Why fasting instructions for oral semaglutide are not optional advice — does this still… Replied, post #51 · Compounds › Oral incretins · 21 Jun 2025 · 27 likes I read post #47 twice before replying, because I had assumed the opposite. Taking the oral product with more water than instructed reduces absorption rather than…
-
Airline travel with a temperature-sensitive injectable — what changed since Replied, post #41 · Devices › Cold chain · 21 Jun 2025 · 2 likes Following, with nothing to contribute beyond having asked the same thing elsewhere.
-
Half-life, steady state, and accumulation worked through Replied, post #94 · Pharmacology › Pharmacokinetics · 10 Jun 2025 · 0 likes I read post #92 twice before replying, because I had assumed the opposite. Practical note on half-life: write down what you expect before you look. The number of times…
-
Journal club: SURMOUNT-1, read without the press release Replied, post #134 · Evidence › Journal club · 10 Jun 2025 · 7 likes What I want from this SURMOUNT-1 thread is the list of things that would need to be true for the claim to hold. If we can write that list, we can check it.
-
A claim built entirely on a subgroup analysis Replied, post #80 · Evidence › Study critique · 6 Jun 2025 · 0 likes No notes. Posting so the count is not one.
-
Half-life, steady state, and accumulation worked through Replied, post #75 · Pharmacology › Pharmacokinetics · 6 Jun 2025 · 2 likes Half-life determines how quickly concentration approaches steady state and does not determine what the steady-state concentration is. Dose and clearance determine that.…
-
A 5 mg vial and a 0.25 mg dose: the arithmetic in full — the long version Replied, post #125 · Practice › Reconstitution · 4 Jun 2025 · 26 likes Swirling versus inverting versus leaving it alone: the vial can be gently warmed (hands around it) and swirled with a rolling motion. Vigorous shaking introduces air…
-
Triple agonism: additive, synergistic, or neither? Replied, post #51 · Compounds › Retatrutide · 29 May 2025 · 4 likes Taking post #48 at face value and following it one step further. Nausea and vomiting were dose-related in the phase 2 work, as they are throughout this class. What is…
-
Antibiotics and a course of something with delayed emptying Replied, post #52 · Practice › Interactions · 29 May 2025 · 26 likes Post #51 and I disagree about the size of the effect, not about the direction. Anticoagulant questions come up regularly and are the clearest case for professional…
-
Pregnancy as an absolute contraindication Replied, post #107 · Safety › Contraindications · 21 May 2025 · 0 likes Where a condition appears as a warning rather than a contraindication, the decision is a clinical one rather than a prohibition. Adding it in case it saves somebody the…
-
Requesting a translation of an existing page Replied, post #16 · Documentation › Wiki requests · 10 May 2025 · 0 likes Authority and authorship: if you think a maintained page needs input from someone with specific expertise (a clinician, an analytical chemist) suggest who might…
-
How Janoshik, Medutest, PeptideMeter and VendorInvestigate differ Replied, post #50 · Sourcing › Independent verification · 5 May 2025 · 4 likes The claim about Janoshik upthread is stronger than its source supports. I have read the source. The source says "associated with" and the post says "causes".
-
Transit times by route, from a logged dataset — the long version Replied, post #87 · Sourcing › Logistics · 28 Apr 2025 · 28 likes The arithmetic in post #84 is right; the assumption feeding it is the part to check. Documentation correct at first presentation is the actual explanation for a transit…
-
[2026 update] Cardiovascular risk: reading the outcome trials as a set Replied, post #22 · Clinical › Comorbidities · 23 Apr 2025 · 14 likes Where the honest answer is "nobody knows", giving it plainly is more useful than a confident synthesis of mechanism and anecdote. That is one dataset and I would not…
-
Journal club: STEP 1 and the treatment-policy estimand — does this still hold? Replied, post #49 · Evidence › Journal club · 19 Apr 2025 · 0 likes The reason STEP 1 keeps being re-asked is that the answer is conditional and people quote it without the condition. It is not that the answer is unknown.
-
BPC-157: what the rodent literature actually shows, and what it does not — a second… Replied, post #33 · Compounds › Repair & healing peptides · 11 Apr 2025 · 0 likes Everything in post #29 holds. The case it does not cover is the one I have. The pentadecapeptide sequence is short and stable enough to survive conditions that would…
-
Consistent declarations and why they matter more than clever ones Replied, post #155 · Sourcing › Logistics · 9 Mar 2025 · 3 likes Split shipments reduce single-point risk and increase the number of transits. Which trade is right depends on what you are protecting against.
-
About the Secretagogues & GH axis category Replied, post #3 · Compounds › Secretagogues & GH axis · 6 Mar 2025 · 0 likes As a member rather than staff: the most useful thing I did when I started reading this category was to work through the tag pages rather than the topic list. The topic…
-
Counter-ion form: the field almost nobody reports — one year on Replied, post #53 · Analytics › COA interpretation · 6 Mar 2025 · 9 likes Right — I had this wrong and I am glad to have read it before it mattered.
-
Pharmaceutical compounding rules, summarised from primary sources Replied, post #152 · Sourcing › Regulatory · 6 Mar 2025 · 2 likes An honest declaration on pharmaceutical compounding rules: I have a prior here and it is strong enough that you should weight what I say downward. Stating it rather…
-
Coming back to: Recording a dissent on a document rather than suppressing it Replied, post #43 · Documentation › Doc review · 4 Mar 2025 · 13 likes Approving a document you have not read is worse than not responding, and it happens because approval feels supportive.
-
Revisiting: Bug report: the reconstitution calculator and a rounding edge case Replied, post #87 · Data & Tools › Calculators · 12 Feb 2025 · 18 likes That matches what I have seen, for whatever a single anecdote is worth.
-
Canadian access and provincial variation Replied, post #75 · Regional › North America · 10 Feb 2025 · 0 likes Emotional language in an appeal does not help, however justified it is. The reviewer is checking criteria and the job is to make them checkable. I have no interest in…
-
Preservatives: function, testing, and limits Replied, post #4 · Pharmacology › Formulation chemistry · 22 Jan 2025 · 27 likes Light sensitivity varies enormously between peptides depending on the residues present. Tryptophan-containing sequences are the ones where it matters most.
-
Research-use-only status: what it means legally and practically — a second dataset Replied, post #64 · Compounds › Other compounds · 15 Jan 2025 · 11 likes Small correction to my own earlier position on Research-use-only status. I had the units the wrong way round, which changes the conclusion by an order of magnitude and…
-
Why mass spectrometry cannot tell you about an epimer Replied, post #18 · Analytics › Mass spectrometry · 3 Jan 2025 · 10 likes Coming back to post #16, because the follow-up matters more than the original answer. Mass accuracy is expressed in parts per million. It is the difference between…
-
Feature request: should a dose-equivalence tool exist at all? Replied, post #4 · Data & Tools › Calculators · 25 Dec 2024 · 10 likes Units: all calculators explicitly require units to be stated. This prevents the decimal-point errors that come from forgetting units. Always verify units in and out.
-
Retatrutide's phase 2 heart-rate signal and how to think about it — the long version Started this topic · Compounds › Retatrutide · 18 Dec 2024 · 11 likes Retatrutide's phase 2 heart-rate signal and how to think about it — the long version Writing it up because I had to work it out twice and would rather nobody else did.…
-
Second pass at: A field-by-field walk through a certificate of analysis Replied, post #140 · Analytics › COA interpretation · 4 Dec 2024 · 29 likes Post #139 answers the question as asked. The question underneath it is different. What would change my mind on field-by-field walk through a certificate is a second…
-
What a stability-indicating method is and how you demonstrate one — one year on Replied, post #73 · Analytics › Method validation · 15 Nov 2024 · 23 likes Building on post #72 rather than restating it. Accuracy: the method measures what you intend to measure. For purity methods, this is tested by spike-and-recover…
-
Domestic fridge temperature mapping: a cheap experiment — what changed since Replied, post #8 · Devices › Cold chain · 10 Nov 2024 · 29 likes Narrowing post #7, because the general version has more than one answer. The version of Domestic fridge temperature mapping that circulates here is a simplification of…
-
Hypertension improvement and when medication needs revisiting — a second dataset Replied, post #123 · Clinical › Comorbidities · 28 Oct 2024 · 20 likes Noted, and thank you for writing it out rather than summarising it.
-
Coming back to: Grapefruit: why this class is not the class that cares Replied, post #19 · Practice › Interactions · 22 Oct 2024 · 1 like A pharmacist can answer most questions in this subcategory in a few minutes with access to a proper interaction database, and that access is the thing a forum does not…
-
Hepatic effects of glucagon receptor agonism: the mechanistic worry Replied, post #35 · Compounds › Retatrutide · 13 Sep 2024 · 24 likes Discontinuation for adverse effects in phase 2 was not negligible at the higher doses. That figure belongs next to the efficacy figure whenever the efficacy figure is…
-
Correlation in a self-tracked dataset: what it can support Replied, post #23 · Research Methods › Statistics · 21 Aug 2024 · 6 likes Baseline imbalance in a randomised trial is expected by chance and adjusting for it post hoc is a choice that should have been pre-specified. Scoping that to what I…
-
Pen wastage and its effect on real cost Replied, post #7 · Access › Pricing · 12 Jul 2024 · 6 likes Post #5 describes the usual case. This is about the unusual one. The cost of an independent submission is worth stating in these threads, because it is the main reason…
-
How this community labels and discusses unrefereed work Replied, post #67 · Evidence › Preprints · 7 Jul 2024 · 25 likes This follows post #66 rather than contradicting it. Adding a null result on community labels. I looked, carefully, and found nothing, and null results deserve posting…